arrow_back Back to App

Drug Price Transparency: Lower Costs for Patients

This bill aims to ensure pharmacies inform patients about price differences for prescription drugs, depending on whether they use health insurance or pay cash. This allows patients to choose the most cost-effective option, potentially reducing their healthcare expenses.
Key points
Pharmacies must disclose if a drug is cheaper when paid for with cash versus using insurance.
Patients with group, individual, Medicare Advantage, and Part D plans will benefit from this price transparency.
The goal is to increase drug price transparency and help patients save money.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2484
Sponsor: Rep. Porter, Katie [D-CA-45]
Process start date: 2021-04-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Lowest Price for Patients Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2484.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-13.

What are the main provisions?

Key points include:

  • Pharmacies must disclose if a drug is cheaper when paid for with cash versus using insurance.
  • Patients with group, individual, Medicare Advantage, and Part D plans will benefit from this price transparency.
  • The goal is to increase drug price transparency and help patients save money.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Porter, Katie [D-CA-45].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health